Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elvira D. Gumbatova"'
Autor:
Oleg V. Goloshchapov, Evgenii I. Olekhnovich, Sergey V. Sidorenko, Ivan S. Moiseev, Maxim A. Kucher, Dmitry E. Fedorov, Alexander V. Pavlenko, Alexander I. Manolov, Vladimir V. Gostev, Vladimir A. Veselovsky, Ksenia M. Klimina, Elena S. Kostryukova, Evgeny A. Bakin, Alexander N. Shvetcov, Elvira D. Gumbatova, Ruslana V. Klementeva, Alexander A. Shcherbakov, Margarita V. Gorchakova, Juan José Egozcue, Vera Pawlowsky-Glahn, Maria A. Suvorova, Alexey B. Chukhlovin, Vadim M. Govorun, Elena N. Ilina, Boris V. Afanasyev
Publikováno v:
BMC Microbiology, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Fecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI). Success of FTM in treatment of rCDI led to a number of studies investigating the effect
Externí odkaz:
https://doaj.org/article/78f30b949a854bfb94166405a8166d93
Autor:
Vera Pawlowsky-Glahn, Vladimir A. Veselovsky, Vadim M. Govorun, Juan José Egozcue, Elena S. Kostryukova, Alexander I. Manolov, Ivan S. Moiseev, Margarita V. Gorchakova, Alexander A. Shcherbakov, Alexey B. Chukhlovin, Vladimir Gostev, Evgenii I. Olekhnovich, Alexander N. Shvetcov, Maxim A. Kucher, Alexander V. Pavlenko, Elvira D. Gumbatova, O. Goloshchapov, Elena N. Ilina, Evgeny A. Bakin, Ruslana V. Klementeva, Boris V. Afanasyev, Sergey Sidorenko, Dmitry E. Fedorov, Ksenia M. Klimina, Maria A. Suvorova
Publikováno v:
BMC Microbiology
BMC Microbiology, Vol 19, Iss 1, Pp 1-13 (2019)
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
BMC Microbiology, 2019, vol. 19, art. núm. 312
Articles publicats (D-IMA)
DUGiDocs – Universitat de Girona
instname
BMC Microbiology, Vol 19, Iss 1, Pp 1-13 (2019)
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
BMC Microbiology, 2019, vol. 19, art. núm. 312
Articles publicats (D-IMA)
DUGiDocs – Universitat de Girona
instname
Background Fecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI). Success of FTM in treatment of rCDI led to a number of studies investigating the effectiveness o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8f37a7b35334534b986848b0029be2
Autor:
Goloshchapov, Oleg V.1 (AUTHOR), Olekhnovich, Evgenii I.2 (AUTHOR) jeniaole01@gmail.com, Sidorenko, Sergey V.3,4 (AUTHOR), Moiseev, Ivan S.1 (AUTHOR), Kucher, Maxim A.1 (AUTHOR), Fedorov, Dmitry E.2 (AUTHOR), Pavlenko, Alexander V.2 (AUTHOR), Manolov, Alexander I.2 (AUTHOR), Gostev, Vladimir V.3,4 (AUTHOR), Veselovsky, Vladimir A.2 (AUTHOR), Klimina, Ksenia M.2 (AUTHOR), Kostryukova, Elena S.2 (AUTHOR), Bakin, Evgeny A.1 (AUTHOR), Shvetcov, Alexander N.1 (AUTHOR), Gumbatova, Elvira D.1 (AUTHOR), Klementeva, Ruslana V.1 (AUTHOR), Shcherbakov, Alexander A.1 (AUTHOR), Gorchakova, Margarita V.1 (AUTHOR), Egozcue, Juan José5 (AUTHOR), Pawlowsky-Glahn, Vera6 (AUTHOR)
Publikováno v:
BMC Microbiology. 12/30/2019, Vol. 19 Issue 1, p1-13. 13p.